Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nileena Velappan is active.

Publication


Featured researches published by Nileena Velappan.


Molecular & Cellular Proteomics | 2006

Using Phage Display to Select Antibodies Recognizing Post-translational Modifications Independently of Sequence Context

John W. Kehoe; Nileena Velappan; Monica Walbolt; Jytte Rasmussen; Dave King; Jianlong Lou; Kristeene Knopp; Peter Pavlik; James D. Marks; Carolyn R. Bertozzi; Andrew Bradbury

Many cellular activities are controlled by post-translational modifications, the study of which is hampered by the lack of specific reagents due in large part to their ubiquitous and non-immunogenic nature. Although antibodies against specifically modified sequences are relatively easy to obtain, it is extremely difficult to derive reagents recognizing post-translational modifications independently of the sequence context surrounding the modification. In this study, we examined the possibility of selecting such antibodies from large phage antibody libraries using sulfotyrosine as a test case. Sulfotyrosine is a post-translational modification important in many extracellular protein-protein interactions, including human immunodeficiency virus infection. After screening almost 8000 selected clones, we were able to isolate a single specific single chain Fv using two different selection strategies, one of which included elution with tyrosine sulfate. This antibody was able to recognize sulfotyrosine independently of its sequence context in test peptides and a number of different natural proteins. Antibody reactivity was lost by antigen treatment with sulfatase or preincubation with soluble tyrosine sulfate, indicating its specificity. The isolation of this antibody signals the potential of phage antibody libraries in the derivation of reagents specific for post-translational modifications, although the extensive screening required indicates that such antibodies are extremely rare.


Trends in Biotechnology | 2003

Antibodies in proteomics I: generating antibodies

Andrew Bradbury; Nileena Velappan; Vittorio Verzillo; Milan Ovecka; Leslie Chasteen; Daniele Sblattero; Roberto Marzari; Jianlong Lou; Robert W. Siegel; Peter Pavlik

The explosion in genome sequencing, and in subsequent DNA array experiments, has provided extensive information on gene sequence, organization and expression. This has resulted in a desire to perform similarly broad experiments on all the proteins encoded by a genome. Panels of specific antibodies, or other binding ligands, will be essential tools in this endeavour. Because traditional immunization will be unlikely to generate antibodies in sufficient quantity, and of the required quality and reproducibility, in vitro selection methods will probably be used. This review--the first of two--examines the strategies available for in vitro antibody selection. The second review discusses the adaptation of these methods to high throughput and the uses to which antibodies, once derived, can be put.


Nucleic Acids Research | 2006

Antibody binding loop insertions as diversity elements

Csaba Kiss; Hugh E. Fisher; Emanuele Pesavento; Minghua Dai; Rosa Valero; Milan Ovecka; Rhiannon L. Nolan; M. Lisa Phipps; Nileena Velappan; Leslie Chasteen; Jennifer S. Martinez; Geoffrey S. Waldo; Peter Pavlik; Andrew Bradbury

In the use of non-antibody proteins as affinity reagents, diversity has generally been derived from oligonucleotide-encoded random amino acids. Although specific binders of high-affinity have been selected from such libraries, random oligonucleotides often encode stop codons and amino acid combinations that affect protein folding. Recently it has been shown that specific antibody binding loops grafted into heterologous proteins can confer the specific antibody binding activity to the created chimeric protein. In this paper, we examine the use of such antibody binding loops as diversity elements. We first show that we are able to graft a lysozyme-binding antibody loop into green fluorescent protein (GFP), creating a fluorescent protein with lysozyme-binding activity. Subsequently we have developed a PCR method to harvest random binding loops from antibodies and insert them at predefined sites in any protein, using GFP as an example. The majority of such GFP chimeras remain fluorescent, indicating that binding loops do not disrupt folding. This method can be adapted to the creation of other nucleic acid libraries where diversity is flanked by regions of relative sequence conservation, and its availability sets the stage for the use of antibody loop libraries as diversity elements for selection experiments.


Protein Engineering Design & Selection | 2008

Using T7 phage display to select GFP-based binders

M. Dai; Jamshid Temirov; E. Pesavento; Csaba Kiss; Nileena Velappan; Peter Pavlik; James H. Werner; A.R.M. Bradbury

Filamentous phage do not display cytoplasmic proteins very effectively. As T7 is a cytoplasmic phage, released by cell lysis, it has been prospected as being more efficient for the display of such proteins. Here we investigate this proposition, using a family of GFP-based cytoplasmic proteins that are poorly expressed by traditional phage display. Using two single-molecule detection techniques, fluorescence correlation spectroscopy and anti-bunching, we show that the number of displayed fluorescent proteins ranges from one to three. The GFP derivatives displayed on T7 contain binding loops able to recognize specific targets. By mixing these in a large background of non-binders, these derivatives were used to optimize selection conditions. Using the optimal selection conditions determined in these experiments, we then demonstrated the selection of specific binders from a library of GFP clones containing heavy chain CDR3 antibody binding loops derived from normal donors inserted at a single site. The selected GFP-based binders were successfully used to detect binding without the use of secondary reagents in flow cytometry, fluorescence-linked immunosorbant assays and immunoblotting. These results demonstrate that specific GFP-based affinity reagents, selected from T7-based libraries, can be used in applications in which only the intrinsic fluorescence is used for detection.


Nucleic Acids Research | 2010

A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins

Nileena Velappan; Hugh E. Fisher; Emanuele Pesavento; Leslie Chasteen; Sara D’Angelo; Csaba Kiss; Michelle Longmire; Peter Pavlik; Andrew Bradbury

Filamentous phage display has been extensively used to select proteins with binding properties of specific interest. Although many different display platforms using filamentous phage have been described, no comprehensive comparison of their abilities to display similar proteins has been conducted. This is particularly important for the display of cytoplasmic proteins, which are often poorly displayed with standard filamentous phage vectors. In this article, we have analyzed the ability of filamentous phage to display a stable form of green fluorescent protein and modified variants in nine different display vectors, a number of which have been previously proposed as being suitable for cytoplasmic protein display. Correct folding and display were assessed by phagemid particle fluorescence, and with anti-GFP antibodies. The poor correlation between phagemid particle fluorescence and recognition of GFP by antibodies, indicates that proteins may fold correctly without being accessible for display. The best vector used a twin arginine transporter leader to transport the displayed protein to the periplasm, and a coil-coil arrangement to link the displayed protein to g3p. This vector was able to display less robust forms of GFP, including ones with inserted epitopes, as well as fluorescent proteins of the Azami green series. It was also functional in mock selection experiments.


Protein Engineering Design & Selection | 2008

A humanized anti-M2 scFv shows protective in vitro activity against influenza

J. Gabbard; Nileena Velappan; R. Di Niro; J. Schmidt; S.M. Tompkins; Andrew Bradbury

M2 is one of the most conserved influenza proteins, and has been widely prospected as a potential universal vaccine target, with protection predominantly mediated by antibodies. In this paper we describe the creation of a humanized single chain Fv from 14C2, a potent monoclonal antibody against M2. We show that the humanized scFv demonstrates similar activity to the parental mAb: it is able to recognize M2 in its native context on cell surfaces and is able to show protective in vitro activity against influenza, and so represents a potential lead antibody candidate for universal prophylactic or therapeutic intervention in influenza.


Diagnostic Microbiology and Infectious Disease | 2001

Rapid identification of pathogenic bacteria by single-enzyme amplified fragment length polymorphism analysis.

Nileena Velappan; James L. Snodgrass; Janetta R. Hakovirta; Babetta L. Marronea; Stefan Burde

Despite major progress in their treatment and prevention, bacterial infections remain a significant cause of morbidity and mortality worldwide. In responding to a disease outbreak, rapid and accurate identification of the bacterial species involved is of paramount importance. Strain level discrimination is desirable to allow selection of treatment modalities, and in the case of a deliberate release, for identification of the source. Single-enzyme amplified fragment length polymorphism (SE-AFLP) analysis was used to perform species and strain identification of subgroup I Bacilli, Yersinia, Staphylococci and Escherichia coli. By careful selection of AFLP primers, it was possible to obtain reproducible and sensitive identification to strain level, even within the highly monomorphic species Bacillus anthracis. SE-AFLP fragments can be analyzed using standard gel electrophoresis, and can be easily scored by visual inspection, due to the low complexity of the fingerprint obtained by this method. These features make SE-AFLP suitable for use in either field or laboratory applications.


Journal of Immunological Methods | 2008

Fluorescence linked immunosorbant assays using microtiter plates.

Nileena Velappan; J. Clements; Csaba Kiss; R. Valero-Aracama; Peter Pavlik; Andrew Bradbury

Fluorescence methods are widely used in the detection of antibodies and other binding events. However, as a general screening and detection tool in microtiter plates, enzyme linked immunosorbant (ELISA) methods predominate. In this paper we explore all parameters for effective use of fluorescence as a plate based detection method, including which microtiter plates can be used, the most effective means of immobilization, and the use of different fluorescent dyes or fluorescent proteins. These studies indicate that fluorescent immunosorbant assays (FLISA) can be used as effectively as enzymatic method in microtiter plate based screening methods, including the screening of phage antibody selections.


BMC Microbiology | 2013

Using phage display selected antibodies to dissect microbiomes for complete de novo genome sequencing of low abundance microbes

Devin W. Close; Fortunato Ferrara; Armand E. K. Dichosa; Sandeep Kumar; Ashlynn R. Daughton; Hajnalka E. Daligault; Krista G. Reitenga; Nileena Velappan; Timothy Sanchez; Srinivas Iyer; Csaba Kiss; Cliff Han; Andrew Bradbury

BackgroundSingle cell genomics has revolutionized microbial sequencing, but complete coverage of genomes in complex microbiomes is imperfect due to enormous variation in organismal abundance and amplification bias. Empirical methods that complement rapidly improving bioinformatic tools will improve characterization of microbiomes and facilitate better genome coverage for low abundance microbes.MethodsWe describe a new approach to sequencing individual species from microbiomes that combines antibody phage display against intact bacteria with fluorescence activated cell sorting (FACS). Single chain (scFv) antibodies are selected using phage display against a bacteria or microbial community, resulting in species-specific antibodies that can be used in FACS for relative quantification of an organism in a community, as well as enrichment or depletion prior to genome sequencing.ResultsWe selected antibodies against Lactobacillus acidophilus and demonstrate a FACS-based approach for identification and enrichment of the organism from both laboratory-cultured and commercially derived bacterial mixtures. The ability to selectively enrich for L. acidophilus when it is present at a very low abundance (<0.2%) leads to complete (>99.8%) de novo genome coverage whereas the standard single-cell sequencing approach is incomplete (<68%). We show that specific antibodies can be selected against L. acidophilus when the monoculture is used as antigen as well as when a community of 10 closely related species is used demonstrating that in principal antibodies can be generated against individual organisms within microbial communities.ConclusionsThe approach presented here demonstrates that phage-selected antibodies against bacteria enable identification, enrichment of rare species, and depletion of abundant organisms making it tractable to virtually any microbe or microbial community. Combining antibody specificity with FACS provides a new approach for characterizing and manipulating microbial communities prior to genome sequencing.


BMC Infectious Diseases | 2017

An extensible framework and database of infectious disease for biosurveillance

Ashlynn R. Daughton; Reid Priedhorsky; Geoffrey Fairchild; Nicholas Generous; Andrea Hengartner; Esteban Abeyta; Nileena Velappan; Antonietta M. Lillo; Karen Stark; Alina Deshpande

Biosurveillance, a relatively young field, has recently increased in importance because of increasing emphasis on global health. Databases and tools describing particular subsets of disease are becoming increasingly common in the field. Here, we present an infectious disease database that includes diseases of biosurveillance relevance and an extensible framework for the easy expansion of the database.

Collaboration


Dive into the Nileena Velappan's collaboration.

Top Co-Authors

Avatar

Andrew Bradbury

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Ashlynn R. Daughton

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Peter Pavlik

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Alina Deshpande

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Leslie Chasteen

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Csaba Kiss

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Esteban Abeyta

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Geoffrey Fairchild

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Nicholas Generous

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Reid Priedhorsky

Los Alamos National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge